Rolf Buslei

10.8k total citations
103 papers, 4.7k citations indexed

About

Rolf Buslei is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Rolf Buslei has authored 103 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Endocrinology, Diabetes and Metabolism, 38 papers in Molecular Biology and 37 papers in Genetics. Recurrent topics in Rolf Buslei's work include Pituitary Gland Disorders and Treatments (48 papers), Glioma Diagnosis and Treatment (36 papers) and Hedgehog Signaling Pathway Studies (14 papers). Rolf Buslei is often cited by papers focused on Pituitary Gland Disorders and Treatments (48 papers), Glioma Diagnosis and Treatment (36 papers) and Hedgehog Signaling Pathway Studies (14 papers). Rolf Buslei collaborates with scholars based in Germany, Austria and United States. Rolf Buslei's co-authors include Michael Buchfelder, Rudolf Fahlbusch, Ingmar Blümcke, Annett Hölsken, Ilker Y. Eyüpoglu, Torsten Pietsch, Eric Hahnen, Florian A. Siebzehnrübl, Helmut K. Wolf and Christopher Nimsky and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rolf Buslei

101 papers receiving 4.6k citations

Peers

Countries citing papers authored by Rolf Buslei

Since Specialization

Citations

This map shows the geographic impact of Rolf Buslei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Buslei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Buslei more than expected).

Fields of papers citing papers by Rolf Buslei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Buslei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Buslei. The network helps show where Rolf Buslei may publish in the future.

Co-authorship network of co-authors of Rolf Buslei

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Buslei. A scholar is included among the top collaborators of Rolf Buslei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Buslei. Rolf Buslei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymph node metastases and recurrence in pT1 colorectal cancer: Prediction with the International Budding Consortium Score—A retrospective, multi‐centric study 2024 ·United European Gastroenterology Journal ·Heather Dawson, John‐Melle Bokhorst, (unknown), Michael Vieth, (unknown), (unknown), Richard Kirsch, (unknown), Gieri Cathomas, Rolf Buslei, David J. Fink, Marie Roumet, Inti Zlobec, Jeroen van der Laak, Irıs D. Nagtegaal, Alessandro Lugli	4
2	Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature 2021 ·Modern Pathology ·Christian Koelsche, Jamal Benhamida, F. Kommoss, Damian Stichel, David Jones, Stefan M. Pfister, Christoph E. Heilig, Stefan Fröhling, Albrecht Stenzinger, Rolf Buslei, Thomas Mentzel, Daniel Baumhoer, Marc Ladanyi, Cristina R. Antonescu, Uta Flucke, Joost van Gorp, Beata Bode‐Lesniewska, Andreas von Deimling, Gunhild Mechtersheimer	24
3	Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas 2020 ·Acta Neuropathologica ·Franz Ricklefs, (unknown), Roman Rotermund, András Piffkó, Simone Schmid, David Capper, Rolf Buslei, Michael Buchfelder, Till Burkhardt, Jakob Matschke, Katrin Lamszus, Manfred Westphal, Ulrich Schüller, Jörg Flitsch	17
4	Rathke's Cleft Cyst as Origin of a Pediatric Papillary Craniopharyngioma 2018 ·Frontiers in Genetics ·Sven-Martin Schlaffer, Michael Buchfelder, Robert Stoehr, Rolf Buslei, Annett Hölsken	19
5	Preclinical transgenic and patient‐derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma 2017 ·Brain Pathology ·Jessica K.R. Boult, John Apps, Annett Hölsken, J. Ciaran Hutchinson, Gabriela Carreno, Laura S. Danielson, Laura Smith, Tobias Bäuerle, Rolf Buslei, Michael Buchfelder, Alex Virasami, Alexander Koers, Owen J. Arthurs, Thomas S. Jacques, Louis Chesler, Juan Pedro Martı́nez-Barberá, Simon P. Robinson	14
6	Pituicytoma—An outlook on possible targeted therapies 2017 ·CNS Neuroscience & Therapeutics ·Klaus Christian Mende, Jakob Matschke, Till Burkhardt, Wolfgang Saeger, Rolf Buslei, Michael Buchfelder, Rudolf Fahlbusch, Manfred Westphal, Jörg Flitsch	12
7	Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin 2016 ·Neurosurgical FOCUS ·Christina Stache, (unknown), Rudolf Fahlbusch, Jörg Flitsch, Michael Buchfelder, Harald Stefanits, Thomas Czech, Udo S. Gaipl, Benjamin Frey, Rolf Buslei, Annett Hölsken	12
8	Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells 2016 ·Pituitary ·Christian Hagel, Rolf Buslei, Michael Buchfelder, Rudolf Fahlbusch, Markus Bergmann, Armin Giese, Jörg Flitsch, Dieter K. Lüdecke, Markus Glatzel, Wolfgang Saeger	23
9	Primary glioblastoma multiforme tumors and recurrence 2015 ·Strahlentherapie und Onkologie ·Carolin Muth, Yvonne Rubner, Sabine Semrau, (unknown), Benjamin Frey, (unknown), Rolf Buslei, Rainer Fietkau, Udo S. Gaipl	29
10	Insights into the Infiltrative Behavior of Adamantinomatous Craniopharyngioma in a New Xenotransplant Mouse Model 2014 ·Brain Pathology ·Christina Stache, Annett Hölsken, (unknown), Andreas Heß, Markus Metzler, Benjamin Frey, Rudolf Fahlbusch, Jörg Flitsch, Michael Buchfelder, Rolf Buslei	37
11	Pituicytoma: overview of treatment strategies and outcome 2011 ·Pituitary ·(unknown), Rolf Buslei, Wolfgang Saeger, Rudolf Fahlbusch	36
12	Increased Reelin Promoter Methylation Is Associated With Granule Cell Dispersion in Human Temporal Lobe Epilepsy 2009 ·Journal of Neuropathology & Experimental Neurology ·Katja Kobow, (unknown), Michelle A.T. Hildebrandt, Jan Hauke, Eric Hahnen, Rolf Buslei, Michael Buchfelder, Daniel J. Weigel, Hermann Stefan, Burkhard S. Kasper, E. Pauli, Ingmar Blümcke	131
13	Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells 2007 ·Experimental Brain Research ·Florian A. Siebzehnrübl, Rolf Buslei, Ilker Y. Eyüpoglu, (unknown), Eric Hahnen, Ingmar Blümcke	84
14	Gliomas: Histopathologic Evaluation of Changes in Directionality and Magnitude of Water Diffusion at Diffusion-Tensor MR Imaging 2006 ·Radiology ·Andreas Stadlbauer, Oliver Ganslandt, Rolf Buslei, Thilo Hammen, Stephan Gruber, Ewald Moser, Michael Buchfelder, Erich Salomonowitz, Christopher Nimsky	154
15	Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases 2006 ·Acta Neuropathologica ·Annett Hölsken, Ilker Y. Eyüpoglu, (unknown), Christian Tränkle, Detlef Dieckmann, Rolf Buslei, Eric Hahnen, Ingmar Blümcke, Florian A. Siebzehnrübl	14
16	In vitro and ex vivo evaluation of second‐generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy 2006 ·Journal of Neurochemistry ·Eric Hahnen, Ilker Y. Eyüpoglu, Lars Brichta, Kirsten Haastert‐Talini, Christian Tränkle, Florian A. Siebzehnrübl, Markus Rießland, Irmgard Hölker, Peter Claus, J. Romstöck, Rolf Buslei, Brunhilde Wirth, Ingmar Blümcke	126
17	Immunopathology of Primary Hypophysitis 2005 ·The American Journal of Surgical Pathology ·Angelika Gutenberg, Rolf Buslei, Rudolf Fahlbusch, Michael Buchfelder, (unknown)	53
18	Malignant glioma—induced neuronal cell death in an organotypic glioma invasion model 2005 ·Journal of neurosurgery ·Ilker Y. Eyüpoglu, Eric Hahnen, (unknown), Florian A. Siebzehnrübl, Rolf Buslei, Rudolf Fahlbusch, Ingmar Blümcke	37
19	Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy 2002 ·Neuroradiology ·HP Schlemmer, Peter Bachert, Marcus Henze, Rolf Buslei, Klaus Herfarth, Jürgen Debus, G. van Kaick	97
20	Neural expression profile of α-synuclein in developing human cortex 1999 ·Neuroreport ·Thomas A. Bayer, Pekka Jäkälä, Tobias Hartmann, Rupert Egensperger, Rolf Buslei, Peter Falkai, Konrad Beyreuther	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact